A phase II pharmacokinetic/pharmacogenetic (PK/PG) study using fixed-dose capecitabine in metastatic breast cancer (MBC). Background: Outcomes after total skin ...
November 3, 2009 (Seattle, Washington) — A new study of the acellular dermal matrix AlloDerm (LifeCell), presented here at Plastic Surgery 2009: American Society of Plastic Surgeons Annual Meeting, ...
SAN ANTONIO--(BUSINESS WIRE)--Acelity, a global advanced wound care and regenerative medicine company, announced today that ALLODERM SELECT DUO TM Regenerative Tissue Matrix is now available in the ...
To describe the use of an acellular dermal allograft (AlloDerm) for patients with insufficient conjunctiva during evisceration and implantation surgery. The medical records of six patients with ...
Please provide your email address to receive an email when new articles are posted on . Patients undergoing reconstruction experienced a shorter duration to drain removal and red breast syndrome with ...